tirzepatide trial results once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, surmount-1 trial tirzepatide weight loss

Obesity Excess weight increases pressure on the intestines

For Tirzepatide: Thyroid Issues: Tirzepatide is not recommended for people with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as it may increase the risk of thyroid tumors

Triple-receptor action Activates GIP, GLP-1 and glucagon receptors in a single molecule

The disadvantage is that lower doses become harder to measure accurately

A 2025 narrative review in Current Reviews in Musculoskeletal Medicine described BPC-157 as showing broad regenerative and protective effects in preclinical studies, especially around tendon, ligament, muscle, bone and nerve healing

Hormonal imbalances can cause many issues, but our health coaches identify the root cause of your imbalance and provide personalized treatment options to restore internal harmony